Qiagen (QGEN) Current Deferred Revenue (2009 - 2010)
Qiagen's (QGEN) quarterly Current Deferred Revenue came in at $21.0 million in Q4 2010, up 31.55% year-on-year from $15.9 million in Q4 2009, and up 31.55% quarter-over-quarter from $15.9 million in Q4 2009.
Qiagen (QGEN) Current Deferred Revenue (2009 - 2010) Analysis & Trends
Qiagen has disclosed Current Deferred Revenue across 2 years of filings, most recently posting $21.0 million for Q4 2010.
- Current Deferred Revenue for Q4 2010 came in at $21.0 million, up 31.55% year-over-year; the trailing twelve-month figure through Dec 2010 was $21.0 million (up 31.55% YoY), and the FY2010 annual result was $21.0 million, up 31.55% from the prior year.
- Current Deferred Revenue came in at $21.0 million for Q4 2010 at Qiagen, up from $15.9 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $21.0 million in Q4 2010 to a low of $15.9 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn |
| 10 | Qiagen | 8.54 Bn | 7.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 20.97 Mn |
| Dec 31, 2009 | 15.94 Mn |